Bio Key International Inc. (BKYI) intrinsic value & 10-year financials
Bio Key International Inc. (BKYI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 8.0% a year to $5.9M, with an average return on invested capital of -174.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.63
- Revenue (FY2025)
- $5.9M
- Revenue growth (10-yr CAGR)
- 8.0%
- ROIC (10-yr avg)
- -174.2%
- Free cash flow (FY2025)
- -$4.7M
BKYI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $5.9M | -$7.2M | — | -$4.7M | -115.0% | -233.0% |
| FY2024 | $6.9M | -$4.3M | — | -$2.9M | -57.9% | -185.2% |
| FY2023 | $7.8M | -$8.5M | — | -$3.8M | -113.8% | -431.2% |
| FY2022 | $7.0M | -$11.9M | — | -$6.3M | -141.4% | -178.8% |
| FY2021 | $5.1M | -$5.1M | — | -$9.0M | -96.6% | -83.9% |
| FY2020 | $2.8M | -$9.7M | — | -$5.0M | -157.6% | -479.6% |
| FY2019 | $2.3M | -$14.6M | — | -$1.9M | -47.1% | -26.2% |
| FY2018 | $4.0M | -$6.9M | — | -$1.7M | -169.8% | -67.7% |
| FY2017 | $6.3M | -$4.3M | — | -$2.6M | -67.8% | -29.3% |
| FY2016 | $3.0M | -$4.2M | — | -$4.5M | -141.2% | -27.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BIO KEY INTERNATIONAL INC has demonstrated mature, steady growth, with revenue compounding at 8.0% annually over the past decade.
BIO KEY INTERNATIONAL INC has historically struggled to out-earn its cost of capital, averaging just -24.9% ROIC.
BIO KEY INTERNATIONAL INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BIO KEY INTERNATIONAL INC is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment.